Algae Dynamics Corp. (OTCQB: ADYNF), a company engaged in developing unique health products and pharmaceuticals that utilize hemp, cannabis and algae oils, is making international news through its current collaboration with the University of Western Ontario (now rebranded as Western University). A recent study conducted collaboratively between the two entities and globally reported (http://cnw.fm/9IE7f) has found that the negative effects of tetrahydrocannabinol (THC)-rich marijuana on the adolescent brain can be reversed through the use of compounds that increase the amounts of GABA, which is a chemical and neurotransmitter in the brain. An article further discussing this reads: “THC exposure reduced the GABA in the brain, the study found. GABA regulates hyperactivity in the brain and has been associated with disorders such as schizophrenia. Negative effects developed later in adulthood from use of marijuana with THC include anxiety, depression and schizophrenia. Drugs that increase the amount of GABA could then reverse the impact of THC and eliminate the schizophrenia-linked symptoms, the research found. ‘We actually went in, and tried to restore the GABA system by activating GABA receptors directly in the prefrontal cortex,’ Western University Professor Steven Laviolette, who spearheaded the research study, said on the Andrew Lawton radio show in Canada (http://cnw.fm/PYP4d). ‘To our amazement, we found that this reversed those schizophrenia-like symptoms,’ he added in an interview with CBC London. He explained that the reversal process can still remain effective many years after the exposure.”
To view the full article, visit http://cnw.fm/1f8WF
About Algae Dynamics Corp.
ADC is engaged in the development of unique health products and pharmaceuticals that utilize hemp, cannabis and algae oils. We have engaged two Canadian universities to provide research into the use of extracts from cannabis oil, which we plan to use to develop products that combine the significant health benefits of Omega-3s derived from algae oil and extracts from cannabis oil. Our research is focused on the use of cannabis oil in the context of cancer, and the use of cannabis derivatives for the development of novel pharmacotherapies for mental health. For more information, visit http://www.algaedynamics.com
More from CannabisNewsBreaks
About CBDWire
CBDWire (CBDW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CBDNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CBDW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CBDW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CBDW brings its clients unparalleled visibility, recognition and brand awareness. CBDW is where news, content and information converge.
For more information please visit https://www.cbdwire.com
Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer
CBDWire (CBDW)
Denver, Colorado
cbdwire.com
303.498.7722 Office
[email protected]
